エピジェネティクス診断の市場規模、シェア、動向分析レポート：製品別（試薬、キット、機器、酵素、サービス）、用途別（腫瘍学、非腫瘍学）、技術別、地域別、セグメント予測、2023年～2030年

エピジェネティクス診断市場の成長と動向

Grand View Research, Inc.の新しい調査レポートによると、世界のエピジェネティクス診断市場規模は、予測期間中15.10%のCAGRで拡大し、2030年までに391億5,000万米ドルに達する見込みです。

この成長の背景には、大うつ病性障害（MDD）の罹患率の上昇があります。WHOによると、2023年には成人の約5％がうつ病性障害に罹患します。さらに、2022年にNCBIが発表した研究によると、世界中で約2億8,000万人がMDDに罹患しています。さらに、エピジェネティック創薬分野における技術進歩も成長に寄与しています。BioMed Central Ltd.が発表した研究によると、抗腫瘍効果をもたらすために、選択的アイソフォーム阻害剤の構築への傾倒が高まっています。

さらに、エピジェネティクスの分野における公的機関や民間団体からの投資の増加は、2023年から2030年にかけて市場を牽引すると予測されています。例えば、2023年3月、単回投与エピジェネティック編集システムのリーダーであるChroma Medicine, Inc.は、1億3,500万米ドルのシリーズB資金調達を完了しました。この資金調達は、エピジェネティック編集技術分野の進歩のためにGoogle Venturesが主導しました。

業界の主要企業は、市場での地位を強化し、顧客基盤を拡大するために様々な戦略を採用しています。例えば、2022年5月、Cardio Diagnostics, Inc.とMana Capital Acquisition Corp.は業務提携を結びました。この契約の目的は、エピジェネティクスの応用を通じて心血管疾患を変革する上場会社を設立することでした。さらに、2022年2月、エレメント・バイオサイエンス社とDovetail Genomics社は、Dovetail社の次世代シーケンスライブラリープレパレーションサービスの性能と価値をElement社のAVITIシステムで実証するための提携を発表しました。

COVID-19パンデミックは、エピジェネティクス研究者がDNAメチル化の変化と骨髄分化に対するCOVID-19ウイルスの影響を調査する機会を創出し、市場にプラスの影響を与えました。2022年にNCBIが発表した研究によると、エピジェネティック修飾は細胞の恒常性とゲノムの維持に重要な役割を果たすだけでなく、ウイルス感染の原因と発症に関する情報も提供します。

エピジェネティクス診断市場レポートハイライト

• 製品別では、試薬セグメントが2022年に31.50%のシェアで市場を独占しました。この成長は、エピジェネティクス調査における試薬需要の高まりに起因しています。
• 技術別では、DNAメチル化セグメントは、慢性疾患治療における需要の増加により、2022年に46.73%の最大の収益シェアを占めました。
• 用途別では、2022年に腫瘍学用途セグメントが69.23%の最大収益シェアを占めました。このセグメントの成長は、がんの発生率の増加により、がん分野におけるエピジェネティクス研究の需要が増加していることに起因しています。
• 北米は2022年に38.18%の収益シェアで市場を独占したが、これは著名な市場プレイヤーの存在と技術的に進んだヘルスケアインフラのためです。さらに、高い研究開発費と相まって、認知度の向上が予測期間中の成長を促進すると予想されます。
• 主要な市場参入企業としては、Roche Diagnostics、Thermo Fisher Scientific, Inc.Ltd.、Novartis AG、Element Biosciences, Inc.、Dovetail Genomics LLC.、Illumina, Inc.、ValiRx Plc.、Abcam plc.などです。

目次

第1章 調査手法と範囲

• 情報調達
• 情報またはデータ分析
• 市場範囲とセグメントの定義
• 市場モデル
  • 企業市場シェア別の市場調査
  • 地域分析

第2章 エグゼクティブサマリー

• 市場スナップショット
• セグメントのスナップショット
• 競合情勢のスナップショット

第3章 エピジェネティクス診断市場の変数、動向、範囲

• 市場系統の見通し
  • 親市場の見通し
  • 関連/補助的な市場見通し
• 市場力学
  • 市場促進要因の分析
  • 市場抑制要因分析
  • 市場機会分析
• エピジェネティクス診断市場の分析ツール
  • ポーターのファイブフォース分析
  • PESTEL分析
  • COVID-19の影響分析

第4章 製品ビジネス分析

• エピジェネティクス診断市場：製品の変動分析
• 試薬
  • 試薬市場、2018-2030（100万米ドル）
• キット
  • キット市場、2018-2030（100万米ドル）
  • チップシーケンスキット
  • 全ゲノム増幅キット
  • 亜硫酸水素塩変換キット
  • RNAシーケンスキット
  • その他
• 機器
  • 機器市場、2018～2030年（100万米ドル）
• 酵素
  • 酵素市場、2018年～2030年（100万米ドル）
• サービス
  • サービス市場、2018-2030（100万米ドル）

第5章 用途ビジネス分析

• エピジェネティクス診断市場：用途の変動分析
• 腫瘍学
  • 腫瘍学市場、2018～2030年（100万米ドル）
  • 固形腫瘍
  • その他
• 非腫瘍学
  • 非腫瘍市場、2018～2030年（100万米ドル）
  • 炎症性疾患
  • 代謝性疾患
  • 感染症
  • 心血管疾患
  • その他

第6章 技術ビジネス分析

• エピジェネティクス診断市場：技術変動分析
• DNAメチル化
  • DNAメチル化市場、2018年～2030年（100万米ドル）
• ヒストンのメチル化
  • ヒストンメチル化市場、2018年～2030年（100万米ドル）
• ヒストンのアセチル化
  • ヒストンアセチル化市場、2018年～2030年（100万米ドル）
• 大きな非コードRNA
  • 大規模な非コーディング RNA市場、2018～2030年（100万米ドル）
• マイクロRNA修飾
  • マイクロRNA修飾市場、2018年～2030年（100万米ドル）
  • クロマチン構造市場、2018年～2030年（100万米ドル）

第7章 地域ビジネス分析

• エピジェネティクス診断市場シェア、地域別、2022年および2030年
• 北米
  • SWOT分析
  • 北米のエピジェネティクス診断市場、2018年～2030年（100万米ドル）
  • 米国
  • カナダ
• 欧州
  • SWOT分析
  • 欧州のエピジェネティクス診断市場、2018年～2030年（100万米ドル）
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • デンマーク
  • スウェーデン
  • ノルウェー
• アジア太平洋地域
  • SWOT分析
  • アジア太平洋地域のエピジェネティクス診断市場、2018年～2030年（100万米ドル）
  • 日本
  • 中国
  • インド
  • オーストラリア
  • タイ
  • 韓国
• ラテンアメリカ
  • SWOT分析
  • ラテンアメリカのエピジェネティクス診断市場、2018～2030年（100万米ドル）
  • ブラジル
  • メキシコ
  • アルゼンチン
• MEA
  • SWOT分析
  • MEAエピジェネティクス診断市場、2018年～2030年（100万米ドル）
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第8章 競合情勢

• 会社分類
• 戦略マッピング
• 企業の市場シェア分析、2022年
• 企業プロファイル・一覧表
  • Roche Diagnostics
  • Thermo Fisher Scientific, Inc.
  • Eisai Co. Ltd.
  • Novartis AG
  • Element Biosciences, Inc.
  • Dovetail Genomics LLC.
  • Illumina, Inc.
  • ValiRx Plc.
  • Abcam plc.

List of Tables

• Table 1 List of Abbreviation
• Table 2 North America Epigenetics diagnostics market, by country, 2018 - 2030 (USD Million)
• Table 3 North America Epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
• Table 4 North America Epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
• Table 5 North America Epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
• Table 6 U.S. Epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
• Table 7 U.S. Epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
• Table 8 U.S. Epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
• Table 9 Canada Epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
• Table 10 Canada Epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
• Table 11 Canada Epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
• Table 12 Europe Epigenetics diagnostics market, by country, 2018 - 2030 (USD Million)
• Table 13 Europe Epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
• Table 14 Europe Epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
• Table 15 Europe Epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
• Table 16 UK Epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
• Table 17 UK Epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
• Table 18 UK Epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
• Table 19 Germany Epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
• Table 20 Germany Epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
• Table 21 Germany Epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
• Table 22 France Epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
• Table 23 France Epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
• Table 24 France Epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
• Table 25 Italy Epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
• Table 26 Italy Epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
• Table 27 Italy Epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
• Table 28 Spain Epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
• Table 29 Spain Epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
• Table 30 Spain Epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
• Table 31 Denmark Epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
• Table 32 Denmark Epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
• Table 33 Denmark Epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
• Table 34 Sweden Epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
• Table 35 Sweden Epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
• Table 36 Sweden Epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
• Table 37 Norway Epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
• Table 38 Norway Epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
• Table 39 Norway Epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
• Table 40 Asia Pacific Epigenetics diagnostics market, by country, 2018 - 2030 (USD Million)
• Table 41 Asia Pacific Epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
• Table 42 Asia Pacific Epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
• Table 43 Asia Pacific Epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
• Table 44 China Epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
• Table 45 China Epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
• Table 46 China Epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
• Table 47 Japan Epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
• Table 48 Japan Epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
• Table 49 Japan Epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
• Table 50 India Epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
• Table 51 India Epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
• Table 52 India Epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
• Table 53 Australia Epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
• Table 54 Australia Epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
• Table 55 Australia Epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
• Table 56 South Korea Epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
• Table 57 South Korea Epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
• Table 58 South Korea Epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
• Table 59 Thailand Epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
• Table 60 Thailand Epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
• Table 61 Thailand Epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
• Table 62 Latin America Epigenetics diagnostics market, by country, 2018 - 2030 (USD Million)
• Table 63 Latin America Epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
• Table 64 Latin America Epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
• Table 65 Latin America Epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
• Table 66 Brazil Epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
• Table 67 Brazil Epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
• Table 68 Brazil Epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
• Table 69 Mexico Epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
• Table 70 Mexico Epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
• Table 71 Mexico Epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
• Table 72 Argentina Epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
• Table 73 Argentina Epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
• Table 74 Argentina Epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
• Table 75 Middle East and Africa Epigenetics diagnostics market, by country, 2018 - 2030 (USD Million)
• Table 76 Middle East and Africa Epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
• Table 77 Middle East and Africa Epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
• Table 78 Middle East and Africa Epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
• Table 79 South Africa Epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
• Table 80 South Africa Epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
• Table 81 South Africa Epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
• Table 82 Saudi Arabia Epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
• Table 83 Saudi Arabia Epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
• Table 84 Saudi Arabia Epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
• Table 85 UAE Epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
• Table 86 UAE Epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
• Table 87 UAE Epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
• Table 88 Kuwait Epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
• Table 89 Kuwait Epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
• Table 90 Kuwait Epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Market Research Process
• Fig. 2 Information Procurement
• Fig. 3 Primary Research Pattern
• Fig. 4 Market Research Approaches
• Fig. 5 Value Chain-Based Sizing & Forecasting
• Fig. 6 Market Formulation & Validation
• Fig. 7 Epigenetics Diagnostics Market Segmentation
• Fig. 8 Market Snapshot, 2022
• Fig. 9 Market Trends & Outlook
• Fig. 10 Market Driver Relevance Analysis (Current & Future Impact)
• Fig. 11 Market Restraint Relevance Analysis (Current & Future Impact)
• Fig. 12 PESTEL Analysis
• Fig. 13 Porter's Five Forces Analysis
• Fig. 14 Global Epigenetics Diagnostics Market: Product Key Takeaways
• Fig. 15 Global Epigenetics Diagnostics Market: Product Movement Analysis
• Fig. 16 Global Epigenetics Diagnostics Market, For Reagents, 2018 - 2030 (USD Million)
• Fig. 17 Global Epigenetics Diagnostics Market, For Kits, 2018 - 2030 (USD Million)
• Fig. 18 Global Epigenetics Diagnostics Market, For Instruments, 2018 - 2030 (USD Million)
• Fig. 19 Global Epigenetics Diagnostics Market, For Enzymes, 2018 - 2030 (USD Million)
• Fig. 20 Global Epigenetics Diagnostics Market, For Services, 2018 - 2030 (USD Million)
• Fig. 21 Global Epigenetics Diagnostics Market: Application Key Takeaways
• Fig. 22 Global Epigenetics Diagnostics Market: Application Movement Analysis
• Fig. 23 Global Epigenetics Diagnostics Market, For Oncology, 2018 - 2030 (USD Million)
• Fig. 24 Global Epigenetics Diagnostics Market, For Non-oncology, 2018 - 2030 (USD Million)
• Fig. 25 Global Epigenetics Diagnostics Market: Technology Key Takeaways
• Fig. 26 Global Epigenetics Diagnostics Market: Technology Movement Analysis
• Fig. 27 Global Epigenetics Diagnostics Market, For DNA Methylation, 2018 - 2030 (USD Million)
• Fig. 28 Global Epigenetics Diagnostics Market, For Histone Methylation, 2018 - 2030 (USD Million)
• Fig. 29 Global Epigenetics Diagnostics Market, For Histone Acetylation, 2018 - 2030 (USD Million)
• Fig. 30 Global Epigenetics Diagnostics Market, For Large noncoding RNA, 2018 - 2030 (USD Million)
• Fig. 31 Global Epigenetics Diagnostics Market, For MicroRNA modification, 2018 - 2030 (USD Million)
• Fig. 32 Global Epigenetics Diagnostics Market, For Chromatin Structure, 2018 - 2030 (USD Million)
• Fig. 33 Regional Marketplace: Key Takeaways
• Fig. 34 Regional Outlook, 2022 & 2030
• Fig. 35 Global Epigenetics Diagnostics Market: Region Movement Analysis
• Fig. 36 North America Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
• Fig. 37 U.S. Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
• Fig. 38 Canada Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
• Fig. 39 Europe Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
• Fig. 40 Germany Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
• Fig. 41 UK Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
• Fig. 42 France Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
• Fig. 43 Italy Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
• Fig. 44 Spain Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
• Fig. 45 Denmark Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
• Fig. 46 Sweden Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
• Fig. 47 Norway Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
• Fig. 48 Asia Pacific Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
• Fig. 49 Japan Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
• Fig. 50 China Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
• Fig. 51 India Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
• Fig. 52 Australia Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
• Fig. 53 South Korea Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
• Fig. 54 Thailand Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
• Fig. 55 Latin America Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
• Fig. 56 Brazil Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
• Fig. 57 Mexico Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
• Fig. 58 Argentina Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
• Fig. 59 Middle East And Africa Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
• Fig. 60 South Africa Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
• Fig. 61 Saudi Arabia Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
• Fig. 62 UAE Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
• Fig. 63 Kuwait Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)

Epigenetics Diagnostics Market Growth & Trends

The global epigenetics diagnostic market size is expected to reach USD 39.15 billion by 2030, expanding at a CAGR of 15.10% over the forecast period, according to a new study by Grand View Research, Inc. The growth is attributed to the rising incidence of major depressive disorder (MDD). According to WHO, in 2023, around 5% of adults suffer from depressive disorder. Furthermore, according to a study published by NCBI in 2022, around 280 million people are affected by MDD across the globe. Additionally, technological advancement in the field of epigenetic drug discovery is also contributing to the growth. A study published by BioMed Central Ltd. states that there is an increasing inclination towards selective isoform inhibitor construction to produce anti-tumor effects.

Moreover, increasing investment from public and private organizations in the field of epigenetics is anticipated to drive the market during 2023-2030. For instance, in March 2023, Chroma Medicine, Inc., a leader in single-dose epigenetic editing systems, completed a USD 135 million Series B funding. The financing was led by Google Ventures for the advancement in the field of epigenetic editing technology.

Key players in the industry are adopting various strategies to strengthen their market position and expand their customer base. For instance, in May 2022, Cardio Diagnostics, Inc., and Mana Capital Acquisition Corp. entered a business agreement. The goal of this agreement was to create a publicly listed company to transform cardiovascular disease through the application of epigenetics. Moreover, in February 2022, Element Bioscience, Inc., and Dovetail Genomics announced a partnership to demonstrate the performance and value of Dovetail's next-generation sequencing library prep service on Element's AVITI system.

The COVID-19 pandemic has positively impacted the market by creating opportunities for epigenetics researchers to study the impact of the COVID-19 virus on DNA methylation changes and myeloid differentiation. A study published by NCBI in 2022 states that epigenetic modification not only plays a crucial role in the maintenance of cellular homeostasis and the genome but also provides information about the cause and development of virus infection.

Epigenetics Diagnostics Market Report Highlights

• Based on product, the reagent segment dominated the market with a share of 31.50% in 2022. The growth is attributed to the rising demand for reagents in epigenetic research studies.
• Based on technology, the DNA methylation segment accounted for the largest revenue share of 46.73% in 2022, owing to its increasing demand in chronic disease treatment.
• Based on application, the oncology application segment accounted for the largest revenue share of 69.23% in 2022. The segment growth is attributed to the increasing demand for epigenetics research in the field of cancer owing to its growing incidences.
• North America dominated the market with a revenue share of 38.18% in 2022, owing to the presence of prominent market players and technologically advanced healthcare infrastructure. Moreover, rising awareness coupled with high R&D expenditure is anticipated to drive growth over the forecast period.
• Some of the major players in the market are Roche Diagnostics, Thermo Fisher Scientific, Inc., Eisai Co. Ltd., Novartis AG, Element Biosciences, Inc., Dovetail Genomics LLC., Illumina, Inc., ValiRx Plc., and Abcam plc.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Information Procurement
• 1.2. Information Or Data Analysis
• 1.3. Market Scope & Segment Definition
• 1.4. Market Model
  • 1.4.1. Market Study, By Company Market Share
  • 1.4.2. Regional Analysis

Chapter 2. Executive Summary

• 2.1. Market Snapshot
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Epigenetics Diagnostics Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Increasing prevalence of cancer
    • 3.2.1.2. Rise in number of geriatric patients
    • 3.2.1.3. Expanding governmental initiatives in the epigenetics field
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. Worries about diagnoses using epigenetics in terms of standardization
    • 3.2.2.2. Lack of skilled professionals
  • 3.2.3. Market opportunity analysis
    • 3.2.3.1. Improvement in healthcare infrastructure in developing economies
• 3.3. Epigenetics Diagnostics Market Analysis Tools
  • 3.3.1. Porter's Five Forces Analysis
  • 3.3.2. PESTEL Analysis
  • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Product Business Analysis

• 4.1. Epigenetics Diagnostics Market: Product Movement Analysis
• 4.2. Reagents
  • 4.2.1. Reagents Market, 2018 - 2030 (USD Million)
• 4.3. Kits
  • 4.3.1. Kits Market, 2018 - 2030 (USD Million)
  • 4.3.2. Chip Sequencing Kit
    • 4.3.2.1. Chip sequencing kit Market, 2018 - 2030 (USD Million)
  • 4.3.3. Whole Genomic Amplification kit
    • 4.3.3.1. Whole Genomic Amplification Kit Market, 2018 - 2030 (USD Million)
  • 4.3.4. Bisulfite Conversion Kit
    • 4.3.4.1. Bisulfite Conversion Kit Market, 2018 - 2030 (USD Million)
  • 4.3.5. RNA Sequencing Kit
    • 4.3.5.1. RNA Sequencing Kit Market, 2018 - 2030 (USD Million)
  • 4.3.6. Others
    • 4.3.6.1. Others Market, 2018 - 2030 (USD Million)
• 4.4. Instruments
  • 4.4.1. Instruments Market, 2018 - 2030 (USD Million)
• 4.5. Enzymes
  • 4.5.1. Enzymes Market, 2018 - 2030 (USD Million)
• 4.6. Services
  • 4.6.1. Services Market, 2018 - 2030 (USD Million)

Chapter 5. Application Business Analysis

• 5.1. Epigenetics Diagnostics Market: Application Movement Analysis
• 5.2. Oncology
  • 5.2.1. Oncology Market, 2018 - 2030 (USD Million)
  • 5.2.2. Solid Tumors
    • 5.2.2.1. Solid Tumors Market, 2018 - 2030 (USD Million)
  • 5.2.3. Others
    • 5.2.3.1. Others Market, 2018 - 2030 (USD Million)
• 5.3. Non-oncology
  • 5.3.1. Non-oncology Market, 2018 - 2030 (USD Million)
  • 5.3.2. Inflammatory Diseases
    • 5.3.2.1. Inflammatory Diseases Market, 2018 - 2030 (USD Million)
  • 5.3.3. Metabolic Diseases
    • 5.3.3.1. Metabolic Diseases Market, 2018 - 2030 (USD Million)
  • 5.3.4. Infectious Diseases
    • 5.3.4.1. Infectious Diseases Market, 2018 - 2030 (USD Million)
  • 5.3.5. Cardiovascular Diseases
    • 5.3.5.1. Cardiovascular Diseases Market, 2018 - 2030 (USD Million)
  • 5.3.6. Others
    • 5.3.6.1. Others Market, 2018 - 2030 (USD Million)

Chapter 6. Technology Business Analysis

• 6.1. Epigenetics Diagnostics Market: Technology Movement Analysis
• 6.2. DNA Methylation
  • 6.2.1. DNA Methylation Market, 2018 - 2030 (USD Million)
• 6.3. Histone Methylation
  • 6.3.1. Histone Methylation Market, 2018 - 2030 (USD Million)
• 6.4. Histone Acetylation
  • 6.4.1. Histone Acetylation Market, 2018 - 2030 (USD Million)
• 6.5. Large noncoding RNA
  • 6.5.1. Large noncoding RNA Market, 2018 - 2030 (USD Million)
• 6.6. MicroRNA modification
  • 6.6.1. MicroRNA modification Market, 2018 - 2030 (USD Million)
  • 6.7.1. Chromatin Structure Market, 2018 - 2030 (USD Million)

Chapter 7. Regional Business Analysis

• 7.1. Epigenetics Diagnostics Market Share By Region, 2022 & 2030
• 7.2. North America
  • 7.2.1. SWOT Analysis
  • 7.2.2. North America Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
  • 7.2.3. U.S.
    • 7.2.3.1. Key Country Dynamics
    • 7.2.3.2. Target Disease Prevalence
    • 7.2.3.3. Competitive Scenario
    • 7.2.3.4. Regulatory Framework
    • 7.2.3.5. Reimbursement Scenario
    • 7.2.3.6. U.S. Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
  • 7.2.4. Canada
    • 7.2.4.1. Key Country Dynamics
    • 7.2.4.2. Target Disease Prevalence
    • 7.2.4.3. Competitive Scenario
    • 7.2.4.4. Regulatory Framework
    • 7.2.4.5. Reimbursement Scenario
    • 7.2.4.6. Canada Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
• 7.3. Europe
  • 7.3.1. SWOT Analysis
  • 7.3.2. Europe Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
  • 7.3.3. UK
    • 7.3.3.1. Key Country Dynamics
    • 7.3.3.2. Target Disease Prevalence
    • 7.3.3.3. Competitive Scenario
    • 7.3.3.4. Regulatory Framework
    • 7.3.3.5. Reimbursement Scenario
    • 7.3.3.6. UK Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
  • 7.3.4. Germany
    • 7.3.4.1. Key Country Dynamics
    • 7.3.4.2. Target Disease Prevalence
    • 7.3.4.3. Competitive Scenario
    • 7.3.4.4. Regulatory Framework
    • 7.3.4.5. Reimbursement Scenario
    • 7.3.4.6. Germany Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
  • 7.3.5. France
    • 7.3.5.1. Key Country Dynamics
    • 7.3.5.2. Target Disease Prevalence
    • 7.3.5.3. Competitive Scenario
    • 7.3.5.4. Regulatory Framework
    • 7.3.5.5. Reimbursement Scenario
    • 7.3.5.6. France Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
  • 7.3.6. Italy
    • 7.3.6.1. Key Country Dynamics
    • 7.3.6.2. Target Disease Prevalence
    • 7.3.6.3. Competitive Scenario
    • 7.3.6.4. Regulatory Framework
    • 7.3.6.5. Reimbursement Scenario
    • 7.3.6.6. Italy Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
  • 7.3.7. Spain
    • 7.3.7.1. Key Country Dynamics
    • 7.3.7.2. Target Disease Prevalence
    • 7.3.7.3. Competitive Scenario
    • 7.3.7.4. Regulatory Framework
    • 7.3.7.5. Reimbursement Scenario
    • 7.3.7.6. Spain Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
  • 7.3.8. Denmark
    • 7.3.8.1. Key Country Dynamics
    • 7.3.8.2. Target Disease Prevalence
    • 7.3.8.3. Competitive Scenario
    • 7.3.8.4. Regulatory Framework
    • 7.3.8.5. Reimbursement Scenario
    • 7.3.8.6. Denmark Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
  • 7.3.9. Sweden
    • 7.3.9.1. Key Country Dynamics
    • 7.3.9.2. Target Disease Prevalence
    • 7.3.9.3. Competitive Scenario
    • 7.3.9.4. Regulatory Framework
    • 7.3.9.5. Reimbursement Scenario
    • 7.3.9.6. Sweden Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
  • 7.3.10. Norway
    • 7.3.10.1. Key Country Dynamics
    • 7.3.10.2. Target Disease Prevalence
    • 7.3.10.3. Competitive Scenario
    • 7.3.10.4. Regulatory Framework
    • 7.3.10.5. Reimbursement Scenario
    • 7.3.10.6. Norway Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
• 7.4. Asia Pacific
  • 7.4.1. SWOT Analysis
  • 7.4.2. Asia Pacific Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
  • 7.4.3. Japan
    • 7.4.3.1. Key Country Dynamics
    • 7.4.3.2. Target Disease Prevalence
    • 7.4.3.3. Competitive Scenario
    • 7.4.3.4. Regulatory Framework
    • 7.4.3.5. Reimbursement Scenario
    • 7.4.3.6. Japan Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
  • 7.4.4. China
    • 7.4.4.1. Key Country Dynamics
    • 7.4.4.2. Target Disease Prevalence
    • 7.4.4.3. Competitive Scenario
    • 7.4.4.4. Regulatory Framework
    • 7.4.4.5. Reimbursement Scenario
    • 7.4.4.6. China Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
  • 7.4.5. India
    • 7.4.5.1. Key Country Dynamics
    • 7.4.5.2. Target Disease Prevalence
    • 7.4.5.3. Competitive Scenario
    • 7.4.5.4. Regulatory Framework
    • 7.4.5.5. Reimbursement Scenario
    • 7.4.5.6. India Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
  • 7.4.6. Australia
    • 7.4.6.1. Key Country Dynamics
    • 7.4.6.2. Target Disease Prevalence
    • 7.4.6.3. Competitive Scenario
    • 7.4.6.4. Regulatory Framework
    • 7.4.6.5. Reimbursement Scenario
    • 7.4.6.6. Australia Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
  • 7.4.7. Thailand
    • 7.4.7.1. Key Country Dynamics
    • 7.4.7.2. Target Disease Prevalence
    • 7.4.7.3. Competitive Scenario
    • 7.4.7.4. Regulatory Framework
    • 7.4.7.5. Reimbursement Scenario
    • 7.4.7.6. Thailand Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
  • 7.4.8. South Korea
    • 7.4.8.1. Key Country Dynamics
    • 7.4.8.2. Target Disease Prevalence
    • 7.4.8.3. Competitive Scenario
    • 7.4.8.4. Regulatory Framework
    • 7.4.8.5. Reimbursement Scenario
    • 7.4.8.6. South Korea Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
• 7.5. Latin America
  • 7.5.1. SWOT Analysis
  • 7.5.2. Latin America Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
  • 7.5.3. Brazil
    • 7.5.3.1. Key Country Dynamics
    • 7.5.3.2. Target Disease Prevalence
    • 7.5.3.3. Competitive Scenario
    • 7.5.3.4. Regulatory Framework
    • 7.5.3.5. Reimbursement Scenario
    • 7.5.3.6. Brazil Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
  • 7.5.4. Mexico
    • 7.5.4.1. Key Country Dynamics
    • 7.5.4.2. Target Disease Prevalence
    • 7.5.4.3. Competitive Scenario
    • 7.5.4.4. Regulatory Framework
    • 7.5.4.5. Reimbursement Scenario
    • 7.5.4.6. Mexico Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
  • 7.5.5. Argentina
    • 7.5.5.1. Key Country Dynamics
    • 7.5.5.2. Target Disease Prevalence
    • 7.5.5.3. Competitive Scenario
    • 7.5.5.4. Regulatory Framework
    • 7.5.5.5. Reimbursement Scenario
    • 7.5.5.6. Argentina Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
• 7.6. MEA
  • 7.6.1. SWOT Analysis
  • 7.6.2. MEA Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
  • 7.6.3. South Africa
    • 7.6.3.1. Key Country Dynamics
    • 7.6.3.2. Target Disease Prevalence
    • 7.6.3.3. Competitive Scenario
    • 7.6.3.4. Regulatory Framework
    • 7.6.3.5. Reimbursement Scenario
    • 7.6.3.6. South Africa Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
  • 7.6.4. Saudi Arabia
    • 7.6.4.1. Key Country Dynamics
    • 7.6.4.2. Target Disease Prevalence
    • 7.6.4.3. Competitive Scenario
    • 7.6.4.4. Regulatory Framework
    • 7.6.4.5. Reimbursement Scenario
    • 7.6.4.6. Saudi Arabia Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
  • 7.6.5. UAE
    • 7.6.5.1. Key Country Dynamics
    • 7.6.5.2. Target Disease Prevalence
    • 7.6.5.3. Competitive Scenario
    • 7.6.5.4. Regulatory Framework
    • 7.6.5.5. Reimbursement Scenario
    • 7.6.5.6. UAE Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
  • 7.6.6. Kuwait
    • 7.6.6.1. Key Country Dynamics
    • 7.6.6.2. Target Disease Prevalence
    • 7.6.6.3. Competitive Scenario
    • 7.6.6.4. Regulatory Framework
    • 7.6.6.5. Reimbursement Scenario
    • 7.6.6.6. Kuwait Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Company Categorization
• 8.2. Strategy Mapping
• 8.3. Company Market Share Analysis, 2022
• 8.4. Company Profiles/Listing
  • 8.4.1. Roche Diagnostics
    • 8.4.1.1. Company overview
    • 8.4.1.2. Financial performance
    • 8.4.1.3. Type benchmarking
    • 8.4.1.4. Strategic initiatives
  • 8.4.2. Thermo Fisher Scientific, Inc.
    • 8.4.2.1. Company overview
    • 8.4.2.2. Financial performance
    • 8.4.2.3. Type benchmarking
    • 8.4.2.4. Strategic initiatives
  • 8.4.3. Eisai Co. Ltd.
    • 8.4.3.1. Company overview
    • 8.4.3.2. Financial performance
    • 8.4.3.3. Type benchmarking
    • 8.4.3.4. Strategic initiatives
  • 8.4.4. Novartis AG
    • 8.4.4.1. Company overview
    • 8.4.4.2. Financial performance
    • 8.4.4.3. Type benchmarking
    • 8.4.4.4. Strategic initiatives
  • 8.4.5. Element Biosciences, Inc.
    • 8.4.5.1. Company overview
    • 8.4.5.2. Financial performance
    • 8.4.5.3. Type benchmarking
    • 8.4.5.4. Strategic initiatives
  • 8.4.6. Dovetail Genomics LLC.
    • 8.4.6.1. Company overview
    • 8.4.6.2. Financial performance
    • 8.4.6.3. Type benchmarking
    • 8.4.6.4. Strategic initiatives
  • 8.4.7. Illumina, Inc.
    • 8.4.7.1. Company overview
    • 8.4.7.2. Financial performance
    • 8.4.7.3. Type benchmarking
    • 8.4.7.4. Strategic initiatives
  • 8.4.8. ValiRx Plc.
    • 8.4.8.1. Company overview
    • 8.4.8.2. Financial performance
    • 8.4.8.3. Type benchmarking
    • 8.4.8.4. Strategic initiatives
  • 8.4.9. Abcam plc.
    • 8.4.9.1. Company overview
    • 8.4.9.2. Financial performance
    • 8.4.9.3. Type benchmarking
    • 8.4.9.4. Strategic initiatives